These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34560263)

  • 1. Development of BET inhibitors as potential treatments for cancer: A new carboline chemotype.
    Hill MD; Quesnelle C; Tokarski J; Fang H; Fanslau C; Haarhoff Z; Kramer M; Madari S; Wiebesiek A; Morrison J; Simmermacher-Mayer J; Sinz M; Westhouse R; Xie C; Zhao J; Huang L; Sheriff S; Yan C; Marsilio F; Everlof G; Zvyaga T; Lee F; Gavai AV; Degnan AP
    Bioorg Med Chem Lett; 2021 Nov; 51():128376. PubMed ID: 34560263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of BET inhibitors as potential treatments for cancer: A search for structural diversity.
    Hill MD; Fang H; Tokarski J; Fanslau C; Haarhoff Z; Huang C; Kramer M; Menard K; Monereau L; Morrison J; Ranasinghe A; Shields EE; Tye CK; Westhouse R; Everlof G; Sheriff S; Yan C; Marsilio F; Zhang L; Zvyaga T; Lee F; Gavai AV; Degnan AP
    Bioorg Med Chem Lett; 2021 Jul; 44():128108. PubMed ID: 33991625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of BET Inhibitors as Potential Treatments for Cancer: Optimization of Pharmacokinetic Properties.
    Hill MD; Fang H; Norris D; Delucca GV; Huang H; DeBenedetto M; Quesnelle C; Schmitz WD; Tokarski JS; Sheriff S; Yan C; Fanslau C; Haarhoff Z; Huang C; Kramer M; Madari S; Menard K; Monereau L; Morrison J; Raghavan N; Shields EE; Simmermacher-Mayer J; Sinz M; Tye CK; Westhouse R; Xie C; Zhang H; Zhang L; Zvyaga T; Lee F; Gavai AV; Degnan AP
    ACS Med Chem Lett; 2022 Jul; 13(7):1165-1171. PubMed ID: 35859878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New 3-tetrazolyl-β-carbolines and β-carboline-3-carboxylates with anti-cancer activity.
    Panice MR; Lopes SMM; Figueiredo MC; Goes Ruiz ALT; Foglio MA; Nazari Formagio AS; Sarragiotto MH; Pinho E Melo TMVD
    Eur J Med Chem; 2019 Oct; 179():123-132. PubMed ID: 31247374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a novel dipeptidyl boronic acid proteasome inhibitor for the treatment of multiple myeloma and triple-negative breast cancer.
    Lei M; Feng H; Bai E; Zhou H; Wang J; Qin Y; Zhang H; Wang X; Liu Z; Hai O; Liu J; Zhu Y
    Org Biomol Chem; 2019 Jan; 17(3):683-691. PubMed ID: 30601533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of β-carboline derivatives with nitrogen mustard moieties against breast cancer.
    Sun J; Wang J; Wang X; Hu X; Cao H; Bai J; Li D; Hua H
    Bioorg Med Chem; 2021 Sep; 45():116341. PubMed ID: 34365102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and Structure-Activity Relationships of Tetrahydro-β-carboline Derivatives as Anticancer and Cancer-chemopreventive Agents.
    Zhang M; Park EJ; Kondratyuk TP; Pezzuto JM; Sun D
    Anticancer Res; 2018 Aug; 38(8):4425-4433. PubMed ID: 30061206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and structure--activity relationships of N²-alkylated quaternary β-carbolines as novel antitumor agents.
    Zhang G; Cao R; Guo L; Ma Q; Fan W; Chen X; Li J; Shao G; Qiu L; Ren Z
    Eur J Med Chem; 2013 Jul; 65():21-31. PubMed ID: 23688697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-Based Design of γ-Carboline Analogues as Potent and Specific BET Bromodomain Inhibitors.
    Ran X; Zhao Y; Liu L; Bai L; Yang CY; Zhou B; Meagher JL; Chinnaswamy K; Stuckey JA; Wang S
    J Med Chem; 2015 Jun; 58(12):4927-39. PubMed ID: 26080064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syntheses of novel β-carboline derivatives and the activities against five tumor-cell lines.
    Bai B; Li XY; Liu L; Li Y; Zhu HJ
    Bioorg Med Chem Lett; 2014 Jan; 24(1):96-8. PubMed ID: 24345445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and Synthesis of DNA-Interactive β-Carboline-Oxindole Hybrids as Cytotoxic and Apoptosis-Inducing Agents.
    Tokala R; Thatikonda S; Vanteddu US; Sana S; Godugu C; Shankaraiah N
    ChemMedChem; 2018 Sep; 13(18):1909-1922. PubMed ID: 30010248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of novel tetrahydro-β-carboline derivatives as antitumor growth and metastasis agents through inhibiting the transforming growth factor-β signaling pathway.
    Zheng C; Fang Y; Tong W; Li G; Wu H; Zhou W; Lin Q; Yang F; Yang Z; Wang P; Peng Y; Pang X; Yi Z; Luo J; Liu M; Chen Y
    J Med Chem; 2014 Feb; 57(3):600-12. PubMed ID: 24417479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of novel 3,9-substituted β-carboline derivatives as anticancer agents.
    Chen YF; Lin YC; Chen JP; Chan HC; Hsu MH; Lin HY; Kuo SC; Huang LJ
    Bioorg Med Chem Lett; 2015 Sep; 25(18):3873-7. PubMed ID: 26235951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of novel β-carboline/acylhydrazone hybrids as potent antitumor agents and overcome drug resistance.
    Li Y; Yan W; Yang J; Yang Z; Hu M; Bai P; Tang M; Chen L
    Eur J Med Chem; 2018 May; 152():516-526. PubMed ID: 29754076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antitumoral activity of novel 3-(2-substituted-1,3,4-oxadiazol-5-yl) and 3-(5-substituted-1,2,4-triazol-3-yl) beta-carboline derivatives.
    Formagio AS; Tonin LT; Foglio MA; Madjarof C; de Carvalho JE; da Costa WF; Cardoso FP; Sarragiotto MH
    Bioorg Med Chem; 2008 Nov; 16(22):9660-7. PubMed ID: 18951806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From Lead to Drug Candidate: Optimization of 3-(Phenylethynyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine Derivatives as Agents for the Treatment of Triple Negative Breast Cancer.
    Zhang CH; Chen K; Jiao Y; Li LL; Li YP; Zhang RJ; Zheng MW; Zhong L; Huang SZ; Song CL; Lin WT; Yang J; Xiang R; Peng B; Han JH; Lu GW; Wei YQ; Yang SY
    J Med Chem; 2016 Nov; 59(21):9788-9805. PubMed ID: 27739679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzoxazinone-containing 3,5-dimethylisoxazole derivatives as BET bromodomain inhibitors for treatment of castration-resistant prostate cancer.
    Xue X; Zhang Y; Wang C; Zhang M; Xiang Q; Wang J; Wang A; Li C; Zhang C; Zou L; Wang R; Wu S; Lu Y; Chen H; Ding K; Li G; Xu Y
    Eur J Med Chem; 2018 May; 152():542-559. PubMed ID: 29758518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular hybrid design, synthesis, in vitro and in vivo anticancer evaluation, and mechanism of action of N-acylhydrazone linked, heterobivalent β-carbolines.
    Guo L; Chen X; Chen W; Ma Q; Fan W; Zhang J; Dai B
    Bioorg Chem; 2020 Mar; 96():103612. PubMed ID: 32007724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and in vitro and in vivo antitumor activities of novel bivalent β-carbolines.
    Shi B; Cao R; Fan W; Guo L; Ma Q; Chen X; Zhang G; Qiu L; Song H
    Eur J Med Chem; 2013 Feb; 60():10-22. PubMed ID: 23279863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and anticancer evaluation of β-carboline-1-one hydantoins.
    Yao CH; Hsieh TC; Song JS; Lee JC
    Future Med Chem; 2020 Feb; 12(3):183-192. PubMed ID: 31813284
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.